ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients-Reference-Cited by-同舟云学术

ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients

Published:2010-10 Issue:4 Volume:139 Page:1190-1197.e3
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Ochi Hidenori,Maekawa Toshiro,Abe Hiromi,Hayashida Yasufumi,Nakano Rikita,Kubo Michaki,Tsunoda Tatsuhiko,Hayes C. Nelson,Kumada Hiromitsu,Nakamura Yusuke,Chayama Kazuaki

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C;Barrera;Hepatology,1995

2. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

3. Peginterferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

4. Factors contributing to ribavirin-induced anemia;Nomura;J Gastroenterol Hepatol,2004

5. Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C;Takaki;J Gastroenterol,2004

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy;BMC Infectious Diseases;2024-03-11

2. Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection;Viruses;2023-02-17

3. Genetic Variants in ITPA and TNFSF10A Are Associated With the Risk of HCV Infection Among Egyptian populations;Egyptian Journal of Chemistry;2022-11-14

4. Disease-associated inosine misincorporation into RNA hinders translation;Nucleic Acids Research;2022-08-18

5. Treatment progress and expansion in Japan: From interferon to direct-acting antiviral;Global Health & Medicine;2021-10-31